Hydroxy bendamustine
CAS: 109882-27-1
Ref. 3D-FH23910
1mg | 136.00 € | ||
2mg | 189.00 € | ||
5mg | 336.00 € | ||
10mg | 498.00 € | ||
25mg | 983.00 € |
Product Information
- 5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
Hydroxy bendamustine is a cytostatic agent that inhibits the proliferation of cancer cells. It is an activated benzyloxymethyl derivative of bendamustine, which is a chemical compound with cytostatic activity that belongs to the class of alkylating agents. Hydroxy bendamustine is used in the treatment of chronic lymphocytic leukemia and other types of cancer. The oral dosage form can be administered once or twice per day and has a higher bioavailability than intravenous administration. The drug binds to specific antibodies in the bloodstream, preventing them from attaching to white blood cells, which prevents their activation and slows down the growth of cancer cells. Hydroxy bendamustine also exhibits anti-inflammatory properties by inhibiting prostaglandin synthesis.
Chemical properties
Technical inquiry about: 3D-FH23910 Hydroxy bendamustine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.